Market Closed -
Other stock markets
|
After market 19:48:50 | |||
134.4 EUR | -1.50% |
|
135.4 | +0.73% |
04:30pm | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
02:43pm | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
Sales 2024 * | 88.75B 82.31B 6,969B | Sales 2025 * | 92.26B 85.57B 7,245B | Capitalization | 351B 326B 27,597B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.96 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.81 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 131,900 |
Yield 2024 * |
3.3% | Yield 2025 * |
3.45% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | -0.78% | ||
1 week | -2.17% | ||
Current month | -1.88% | ||
1 month | -1.13% | ||
3 months | -6.49% | ||
6 months | -9.02% | ||
Current year | -5.17% |
![Extreme 133.9](/images/extremecours_fleche.png)
![Extreme 133](/images/extremecours_fleche.png)
![Extreme 132.78](/images/extremecours_fleche.png)
![Extreme 132.78](/images/extremecours_fleche.png)
![Extreme 132.78](/images/extremecours_fleche.png)
![Extreme 104.12](/images/extremecours_fleche.png)
![Extreme 72.55](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 31/12/88 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 31/12/97 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 04/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 24/04/19 |
D. Davis
BRD | Director/Board Member | 72 | 18/06/14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 21/10/09 |
Date | Price | Change | Volume |
---|---|---|---|
03/07/24 | 134.4 | -1.50% | 2 668 |
02/07/24 | 136.4 | -0.03% | 13,566 |
01/07/24 | 136.5 | -0.37% | 4,030 |
28/06/24 | 137 | +0.13% | 1,078 |
27/06/24 | 136.8 | -0.42% | 1,227 |
Delayed Quote Xetra, July 03, 2024 at 04:35 pm
More quotes![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+54.07% | 816B | |
+38.59% | 634B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B | |
-3.79% | 158B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock